IonQ just bought a semiconductor foundry, launched a 256-qubit data-center machine, and raised 2026 revenue guidance by 60% — while burning more cash per quarter than it books in revenue and issuing 50% more shares in a year. The stock is down 42% over twelve months. Every question about IONQ reduces to one: is owning the fab the thing that finally makes quantum manufacturable — or a $1.8B distraction that dresses up a quantum business still priced at ~53× sales? Five analyst lenses, three scenarios, four horizons.
The stock sits 25% of the way up its own 52-week range and 52% below the October 2025 all-time high, below both the 50-day and 200-day moving averages. The sell-side consensus at $69.25 sits three-quarters of the way up that range — Wall Street is modelling a return most of the way to the peak, the tape is not.
Log price axis — necessary, because the cone spans $13 to $355 and a linear axis would flatten everything below $60 into a single line. Gray = IonQ's actual path: a $9 stock in late 2024, $41.77 at the 2024 close, an $84.64 all-time high on 13 Oct 2025, then a 69% drawdown into a $25.89 low in late July 2026 and a partial recovery to today. Monthly points between the dated anchors are approximated from verified year-end closes and reported monthly moves (May ’26 +59.7%, Jun −26.1%, Jul −31.6%). Colored paths are synthesized scenario midpoints weighted bear 35% · base 42% · bull 23%. The clay circle marks the Street's 12-month consensus of $69.25 — above the base case, below the bull.
The desk starts at bear 35% · base 42% · bull 23% — a deliberately bear-tilted prior for a pre-profit company burning ~$713M a year. Those numbers are a judgment call, so make them yours. Drag to set the bear and bull probabilities (base takes the remainder); the blended target below, the dotted line on the chart, and the prob-weighted row of every scenario card update live.
Each lens below was reasoned independently before any of the others were read, so they genuinely disagree. The spread between the most and least optimistic 12-month target is nearly 4× — which is itself the most honest fact in this report.
Quarterly revenue went from $7.6M (Q1 ’25) to $80.1M (Q2 ’26) — a 10.5× run in five quarters, with Q2 beating its own guidance midpoint by 20%. Superion 256 chips are already in production at SkyWater with deliveries in early 2027, so the 2027 step-up is a manufacturing schedule, not a research hope. $2.0B of cash against $54.5M of debt funds the entire scaling curve without financing risk.
The 60% guidance raise added zero quantum revenue — standalone guidance stayed at $280–290M while SkyWater, which did $317M in 1H on its own, supplied the entire step-up. Strip the foundry at its $1.8B purchase price and the quantum business still carries ~53× guided sales. Gross margin halved; EBITDA loss now exceeds quarterly revenue; shares are up 50% in a year. The CEO sold days after his own raise.
One number governs: $2.0B of cash against a −$712.6M 2026 FCF consensus is 2.8 years of straight-line runway, or ~2.3 if burn keeps compounding as it has (−$124M → −$300M → −$484M TTM). IonQ burned $2.30 of cash per $1 of 2025 revenue. Q2 gross profit was $21.1M against ~$120M of quarterly cash cost. The equity is the funding mechanism.
Owning SkyWater buys queue priority and margin capture — a supply moat, not a technology moat — and it erodes the day a larger foundry decides quantum is a real end market. Nine quantum customers run there, only a third of volume IonQ's: today that third-party base pays for the fab, tomorrow it means rivals walk through the same toll booth. IonQ scores 11/23 on independent benchmarking, behind Quantinuum's 16/23.
Below the 50-day and 200-day, −41.9% over 52 weeks, deeply negative 12-1 momentum. But realized volatility is ~95% annualized, which makes a 12-month 1-sd band of $15.66 – $104.66 — a 6.7×-wide cone in which direction is nearly uninformative. On that distribution, P(reaching the $69.25 consensus) ≈ 29%; P(making a new low below $25.89) ≈ 32%. A new low is more likely than consensus.
Twelve to fourteen firms cover IONQ, and their consensus is 71% above spot. That gap is either the opportunity or the warning — the Street has been walking targets down even while publishing upside.
Selected published targets with their dates. Note the direction of travel underneath the bullish headline: Mizuho lowered its target to $52 on 9 Sep, Weiss Ratings downgraded to Sell on 21 Aug, and Morgan Stanley's $49 sits barely above spot — while Rosenblatt holds $100 and Jefferies $80. MarketBeat's wider 14-analyst panel shows a $67.17 consensus with a 9 buy / 4 hold / 1 sell split and a low target of $35; stockanalysis.com's 12-analyst panel shows $69.25 and 9 Strong Buy / 1 Buy / 2 Hold. Both are used here; the sources disagree, which is itself informative. Ratings and targets as published by each firm — this desk does not endorse them.
Synthesized scenario midpoints, dated mid-year, with returns versus today's $40.47. Note the shape: the bear case is a slow bleed to a cash-and-fab floor, the bull case is a 9× — this is an option payoff, not a price forecast, and the asymmetry widens with every year you hold it.
The entire debate lives in the gap between the blue bar and the olive one. Revenue is climbing fast — and free cash flow is falling faster.
Revenue (sky) goes 43 → 130 → 455 → 760. Free cash flow (olive, below the line) goes −124 → −300 → −713 → −600. Every dollar of new revenue in 2026 arrived alongside roughly $1.60 of new cash burn. Debt (slate) is trivial at ~$55M — this company is financed by issuing equity, not borrowing, which is why the share count is the number that matters most. Capex (clay) was negligible while IonQ was asset-light; owning SkyWater's fabs ends that era. 2024 and 2025 are reported actuals (revenue, capex, FCF, debt per stockanalysis.com); 2026E revenue is the $450–460M guidance midpoint and 2026E FCF is the −$712.6M consensus; 2026E capex/debt and all 2027E figures are desk estimates on the base case, shown at reduced opacity.
Most deep dives build price targets as EPS × an exit multiple. IonQ's reported earnings cannot carry that weight — so this chart exists to show you why every target in this report runs on revenue multiples instead.
Look at the swings: −$3.58, then +$2.04, then +$2.24, then −$5.08. These are not earnings — they are warrant fair-value remeasurements flowing through net income. Q2 ’26's −$1.87B net loss included a $1.65B non-cash warrant charge; the two positive quarters are the same mechanism running in reverse. The operating truth underneath is simpler and worse: adjusted EBITDA of −$120.3M in Q2 (−$95.6M excluding SkyWater deal costs), against $80.1M of revenue. Consensus 2026 EPS is −$1.21; there is no year in any analyst's published model in which this company earns a profit. That is the honest reason the targets here are built on EV/Sales — and the reason the multiple, not the earnings, is what you are actually underwriting.
Read the olive bars as the business, the clay bars as the frontier, and the terracotta bars as the bill. All three are compounding at triple digits.
The chart is the whole argument in one frame. Organic quantum revenue is guided to grow 119% in 2026 ($130M → $285M) — genuinely excellent, and the core of the bull case. But the headline numbers that get quoted — TTM +371%, Q2 +287%, FY26E +250% — are inflated by the SkyWater and Nexus acquisitions, which is why the same guidance raise that lifted total revenue 60% left quantum guidance unchanged. And two of the fastest-growing lines are costs: the adjusted EBITDA loss widened ~230% YoY (−$36.5M → −$120.3M), and the share count grew 50%. A shareholder who held through the year owns a third less of a company growing three times faster.
The whole valuation argument compresses into one disagreement: is owning the fab the thing that turns qubits into a manufacturable product — or a $1.8B distraction that buys revenue instead of earning it?
Over a 3–5 year horizon. Most speculative-tech risk maps cluster in “possible”; IonQ's does not — the hottest cell is occupied, and it is occupied by arithmetic rather than by a competitor.
What breaks: a −$713M 2026 FCF against ~$2.0B forces an equity raise into a weak tape, and 50%-a-year share growth outruns the revenue compounding underneath it.
What breaks: Quantinuum or Google publishes durable below-threshold error correction first and IonQ's 99.99% physical fidelity is re-read as a spec-sheet win on an input nobody buys.
What breaks: the entire base case rests on early-2027 customer deliveries; a two-quarter slip pushes revenue recognition into a year the balance sheet may not reach unaided.
What breaks: at ~31× EV/2026E sales there is no valuation floor — a move to 15× halves the stock with zero change in the business.
What breaks: with the Fed at 3.75–4.00% and a 3.29 beta, any rise in the discount rate hits a zero-terminal-cash-flow story hardest and fastest.
What breaks: a high-profile failure or a run of missed milestones across the sector closes the capital window for everyone at once — low odds, but it is the scenario in which the runway math stops being theoretical.
What breaks: trapped ions have the slowest gate speeds of the major modalities; if fault tolerance is ultimately won on cycle count, superconducting or neutral-atom platforms make the whole trap approach a dead end.
What breaks: fab utilization disappoints, the $1.8B is written down, and the vertical-integration story reads as a capital sink rather than a moat.
What breaks: insiders own 0.51% and the CEO sold days after his own guidance raise — thin alignment makes every disappointment cheaper to absorb at the top than at the bottom.
What breaks: nothing suddenly — but every incremental foundry dollar arrives at ~20% margin, so consolidated gross margin keeps grinding down and disguises system-level economics.
Hover the dotted terms in the prose above, or scan the desk's working definitions here.